To this purpose, we assessed the protein levels of Mcl-1, Bcl-2, Bcl-xL and Noxa after different treatment conditions in U87, LN229 and NCH644 stem-like GBM cells. This evidence concerns the gene PMAIP1 and glioblastoma.